Gilead Sciences Publicizes Fourth Quarter and Full Yr 2022 Monetary Outcomes
Product Gross sales Excluding Veklury Elevated Yr-Over-Yr by 8% for Full Yr 2022 Biktarvy Gross sales Elevated Yr-Over-Yr by 20% for Full Yr 2022 Oncology Gross sales Elevated Yr-Over-Yr by…